Boston Scientific’s full acquisition of Farapulse affirms its confidence that pulsed field ablation (PFA) technology can accelerate the growth of its electrophysiology business.
Boston Scientific first invested in Farapulse in 2014 and currently owns 27% of the Menlo Park, CA-based company. Mary Byron,...







